DiscGenics
Salt Lake City
About DiscGenics
Clinical stage biotechnology company developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $68.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Aug 2020)
- Website: discgenics.com
- Phone: 801-410-0703
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/discgenics-15055 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.